These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7397800)

  • 1. [Ultraviolet spectrophotometry in drug quality control. XXIV. Prediction of spectral behavior of medicinal substances with chromophores of benzene rings in their molecules].
    Krácmar J; Krácmarová J
    Cesk Farm; 1980 Feb; 29(1-2):19-31. PubMed ID: 7397800
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ultraviolet spectrophotometry in drug quality control. XXV. Prediction of spectral behavior of medicinal substances with chromophore nuclei of pyridine, naphthalene, quinoline, and isoquinoline in their molecules].
    Krácmar J; Krácmarová J
    Cesk Farm; 1980 May; 29(3-4):57-66. PubMed ID: 7407948
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ultraviolet spectrophotometry in drug control. XXI. Follow-up on the effects of substitution and solvents in new medicinal substances with chromophores of benzene and pyridine rings in the molecules].
    Krácmar J; Sotolongo MA; Krácmarová J
    Cesk Farm; 1977 Oct; 26(8):345-53. PubMed ID: 608191
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ultraviolet spectrophotometry in the control of drugs. XX. Study on the effect of substitution and solvents in new drugs with chromophores of benzene rings in the molecule].
    Krácmar J; Alvarez M; Sotolongo MA; Krácmarová J
    Cesk Farm; 1976 Sep; 25(7):243-57. PubMed ID: 991285
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ultraviolet spectrophotometry in the control of drugs. XXVII. New therapeutic substances containing chromophores of benzene rings in their molecules. 3. The effect of substitution and solvents].
    Krácmar J; Krácmarová J
    Cesk Farm; 1982 Sep; 31(7):271-8. PubMed ID: 6128076
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ultra-violet spectrophotometry in drug control. Part 23: Conclusions from the spectrophotometric behaviour of drugs with pyridine, naphthalene, quinoline and isoquinoline chromophores (author's transl)].
    Krácmar J; Krácmarová J
    Pharmazie; 1979 Jan; 34(1):27-32. PubMed ID: 432253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [UV-Spectrophotometry in drug control. 19. New drugs with substituted benzene chromophores].
    Krácmar J; Sotolongo MA; Krácmarová ; Petránová J; Horská J
    Pharmazie; 1976; 31(9):614-7. PubMed ID: 1019209
    [No Abstract]   [Full Text] [Related]  

  • 8. Report on the PQRI impurity characterization and quantification best practices survey.
    Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
    Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ultraviolet spectrophotometry in the control of drugs. XXVII. Prediction of spectral behavior of therapeutic drugs with chromophore phenanthrene rings in their molecules].
    Krácmar J; Krácmarová J
    Cesk Farm; 1982 Jan; 31(1):14-23. PubMed ID: 7074688
    [No Abstract]   [Full Text] [Related]  

  • 10. [UV-spectrophotometry in drug control. 39. Spectrophotometric behavior of substances with chromophores and auxochromes in aliphatic chains, in saturated heterocyclics and the heterocyclic compounds: furan, imidazole, thiazole, thiadiazole and oxadiazole].
    Krácmar J; Krácmarová J
    Pharmazie; 1988 Jun; 43(6):424-8. PubMed ID: 3212031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [UV spectrophotometry in drug control. 37. New active substances containing benzene, pyridine and quinoline chromophores in the molecule. 8. Effect of substitution and solvent].
    Krácmar J; Krácmarová J; Kovárová A; Stejskal Z
    Pharmazie; 1988 Mar; 43(3):173-6. PubMed ID: 3380858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ultraviolet spectrophotometry in drug control. V. Effect of substitution and solvents on the behavior of drugs with chromophores of the pyridine nucleus].
    Krácmar J; Krácmarová J; Zýka J
    Cesk Farm; 1968 Feb; 17(2):68-79. PubMed ID: 5663009
    [No Abstract]   [Full Text] [Related]  

  • 13. [The use of derivative spectrophotometry for the identification of drug and narcotic substances extracted from biological objects].
    Kakhanovskiĭ FN; Melenevskiĭ SV
    Sud Med Ekspert; 1992; 35(1):19-22. PubMed ID: 1589886
    [No Abstract]   [Full Text] [Related]  

  • 14. [Some possibilities of using spectrometry in the near infrared region in drug quality control].
    Subert J
    Ceska Slov Farm; 2006 Sep; 55(5):210-2. PubMed ID: 17128590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [UV-spectrophotometry in drug control. 41. Drug substances with chromophores and auxochromes in monocyclic compounds (pyrazolone, pyrazolidine, pyridazine, pyrimidine and pyrazine) and bicyclic compounds (benzoxazole, imidazole, benzthiazole and indene)].
    Krácmar J; Krácmarová J; Remsová M; Kovárová A
    Pharmazie; 1988 Oct; 43(10):681-6. PubMed ID: 3212012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [How to assure the quality of a medicinal product ].
    Agosti ME
    Medicina (B Aires); 2003; 63(5):450-2. PubMed ID: 14628657
    [No Abstract]   [Full Text] [Related]  

  • 17. [UV-spectrophotometry in drug control. 33. New drugs with benzene, pyridine, quinoline and phenanthrene chromophores in the molecule. 6. The effect of substitution and solvents].
    Krácmar J; Krácmarová J; Stejskal Z
    Pharmazie; 1987 Jan; 42(1):18-22. PubMed ID: 2953035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sensitive spectrophotometric method for the determination of sulfonamides in pharmaceutical preparations.
    Nagaraja P; Naik SD; Shrestha AK; Shivakumar A
    Acta Pharm; 2007 Sep; 57(3):333-42. PubMed ID: 17878112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quality control of drugs--the contribution of pharmacy to drug safety standards. The historical development of the working group on drug quality control--pharmaceutical analysis of the German Pharmaceutical Society. 1].
    Göber B; Kny L; Langner A
    Pharm Unserer Zeit; 2000 May; 29(3):174-82. PubMed ID: 10881602
    [No Abstract]   [Full Text] [Related]  

  • 20. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.